NorthCoast Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

NorthCoast Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$565K	Sell	3,113 -13,567	-81%	-$2.65M	0.02%	332
2021 Q2	$3.36M	Buy	16,680 +1,795	+12%	+$375K	0.12%	133
2021 Q1	$3.2M	Buy	14,885 +8,233	+124%	+$1.81M	0.13%	129
2020 Q4	$1.57M	Sell	6,652 -14,447	-68%	-$3.31M	0.07%	165
2020 Q3	$5.74M	Buy	21,099 +14,354	+213%	+$3.96M	0.29%	74
2020 Q2	$1.96M	Sell	6,745 -1,342	-17%	-$364K	0.11%	114
2020 Q1	$1.92M	Buy	+8,087	New	+$1.86M	0.12%	105
2019 Q3	–	Sell	-6,327	Closed	-$1.16M	–	279
2019 Q2	$1.16M	Buy	6,327 +247	+4%	+$43.2K	0.07%	143
2019 Q1	$1.12M	Sell	6,080 -806	-12%	-$149K	0.07%	149
2018 Q4	$1.14M	Buy	6,886 +3,328	+94%	+$577K	0.09%	133
2018 Q3	$686K	Sell	3,558 -76	-2%	-$13.5K	0.04%	167
2018 Q2	$618K	Buy	3,634 +76	+2%	+$11.8K	0.06%	143
2018 Q1	$580K	Sell	3,558 -912	-20%	-$149K	0.05%	153
2017 Q4	$670K	Hold	4,470	–	–	0.06%	149
2017 Q3	$680K	Sell	4,470 -1,599	-26%	-$241K	0.08%	134
2017 Q2	$782K	Buy	+6,069	New	+$731K	0.09%	139

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NorthCoast Asset Management's VRTX Position: Q3 2021 in Review

NorthCoast Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 81% in Q3 2021, selling an estimated $2.65M and leaving 3,113 shares worth $565K. The position accounts for 0.02% of the portfolio, ranked #332.

NorthCoast Asset Management first reported a position in VRTX in Q2 2017 and has held it in 16 quarters since. The position peaked at $5.74M in Q3 2020. 934 funds tracked by Wall St. Rank hold VRTX as of Q3 2021.

NorthCoast Asset Management held 3,113 shares of Vertex Pharmaceuticals worth $565K as of Q3 2021.
NorthCoast Asset Management sold 13,567 Vertex Pharmaceuticals shares in Q3 2021, an estimated $2.65M.
Vertex Pharmaceuticals made up 0.02% of NorthCoast Asset Management's portfolio in Q3 2021, its #332 holding.
NorthCoast Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2017 and has held it in 16 quarters since.
NorthCoast Asset Management's Vertex Pharmaceuticals position peaked at $5.74M in Q3 2020.
934 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.